Crossmark

Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P

Crossref DOI link: https://doi.org/10.1007/s10147-025-02707-3

Published Online: 2025-02-12

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kato, Masashi https://orcid.org/0000-0002-3454-3658
Sato, Hiroyuki

Naito, Yushi

Yamamoto, Akiyuki

Kawanishi, Hideji

Nakano, Yojiro

Nishikimi, Toshinori

Kobayashi, Masataka

Kondo, Atsuya

Hirabayashi, Hiroki

Katsuno, Satoshi

Sakamoto, Fumitoshi

Kimura, Tohru

Yamamoto, Shigeki

Araki, Hidemori

Tochigi, Kosuke

Ito, Fumihiro

Hatsuse, Hatsuro

Sassa, Naoto

Hirakawa, Akihiro

Akamatsu, Shusuke

Tsuzuki, Toyonori
Funding

Funding for this research was provided by:

AstraZeneca

Nagoya University
License Information

Text and Data Mining valid from 2025-02-12

Version of Record valid from 2025-02-12
More Information

Article History

Received: 14 November 2024

Accepted: 14 January 2025

First Online: 12 February 2025

Declarations

:

: MK received honoraria from AstraZeneca and Janssen and research grant from AstraZeneca; TT received honoraria from AstraZeneca, Bristol-Myers Squibb, Janssen, and Nippon Kayaku, and research grants from Bristol-Myers Squibb, Ferring, and SBI Pharma.

Document is current

Any future updates will be listed below